欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1798/001
药品名称
Azalonum
活性成分
cinnarizine 20.0 mg
dimenhydrinate 40.0 mg
剂型
Tablet
上市许可持有人
Medochemie Limited Cyprus
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Greece (GR)
Latvia (LV)
Azalonum 20 mg/40 mg tabletes
Lithuania (LT)
AZALONUM 20 mg/40 mg tabletės
Estonia (EE)
AZALONUM
Bulgaria (BG)
Azalonum
Cyprus (CY)
Azalonum 20,g/40mg tablets
Czechia (CZ)
Medovert 20 mg/40 mg tablety
Romania (RO)
Azalonum 20 mg/40 mg comprimate
Slovakia (SK)
MEDOVERT 20 mg/40 mg tablety
Malta (MT)
Azalonum 20mg/40mg tablets
Croatia (HR)
Azalonum 20 mg/40 mg tablete
许可日期
2019/03/13
最近更新日期
2023/09/15
药物ATC编码
N07CA52 cinnarizine, combinations
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR
|
SE/H/1798/001_PAR
Date of last change:2019/11/14
Final PL
|
SE/H/1798/001_Final PL
Date of last change:2019/11/06
Final SPC
|
SE/H/1798/001_Final SPC
Date of last change:2019/11/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase